Top listed pharmaceutical companies have engaged in the ‘speed battle’over the next generation antiulcer drug
CJ Healthcare, Yuhan Corporation and Dawwoong Pharmaceutical are engaged in a speed battle over the P-CAB-type (Potassium Competitive Acid Blocker) drug, receivingattention as the next generation antiulcer drug.
The PPI drug currently dominating in the antiulcer drug market has the following dra...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
